In a cohort of more than 300 patients with relapsed or refractory disease, 99.1% treated with the CD19/CD22-directed product ...
Treatment with bicistronic CD19/CD22 CAR-T cell therapy has shown event-free survival improvements in children with relapsed ...
Biden Administration says that manufacturers of sickle cell gene therapies agree to participate in access model in 2025.
SAN DIEGO -- Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) lived significantly longer without ...
Though he doesn't remember it, Branden Baptiste had his first sickle cell crisis at age 2. Through elementary school, he was ...
The scAtlasVAE model integrates scRNA-seq data to create a CD8+ T cell atlas, enhancing understanding of immune responses in ...
Debilitating chronic fatigue syndrome creates conditions where a kind of immune cell that identifies and kills pathogens, ...
UCSF scientists have developed a "molecular GPS" to guide immune cells into the brain and kill tumors without harming healthy ...
SciTech Development, a clinical-stage pharmaceutical company focused on advancements in cancer treatment, is excited to share ...
Recent advances in immunotherapy research have revealed crucial roles for new immune cells in combating cancer, leading to ...